We are live on ! Find out more
FEED

ENvue Medical Inc

5 hedge funds and large institutions have $142K invested in ENvue Medical Inc in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.03%0.02% (-0.01%)

29% less funds holding

Funds holding: 75 (-2)

30% less capital invested

Capital invested by funds: $204K → $142K (-$61.5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$1.94K

FEED Hedge Fund Activity: Q2 2023 in Review

5 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q2 2023, worth a combined $142K — down 30% from $204K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of FEED and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $1.94K. The largest seller was Vanguard Group, cutting an estimated $52.1K.

  • 5 institutional investors held ENvue Medical Inc (FEED) as of Q2 2023, down from 7 in Q1 2023.
  • Funds reported $142K of ENvue Medical Inc stock for Q2 2023, down 30% quarter-over-quarter.
  • 0 funds opened new ENvue Medical Inc positions in Q2 2023 and 2 closed out, a net change of -2 holders.
  • The largest ENvue Medical Inc buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $1.94K added.
  • The largest ENvue Medical Inc seller in Q2 2023 was Vanguard Group, an estimated $52.1K sold.

Based on aggregated 13F filings for Q2 2023.